Vaccines
created Here

TO HELP PROTECT
THEM THERE


banner 1

Before you know our vax,
get to know us

We focus solely on developing life-saving vaccines to fight infectious diseases. Novavax is here to make a difference. We never rest in our quest to protect the health of people everywhere.

Novavax was instrumental in the fight against the COVID-19 pandemic across the globe

Authorized for use in more
than 40 countries

~100 million doses delivered
around the world

Accurate as of October 2023

hand
As the world
evolves…
We're evolving with it.

We continue to expand our innovation and are working on investigational vaccines in the following areas:

COVID-19

Flu

Flu and Covid‑19 combination

banner 2

Why protein-based TECHNOLOGY?

Tried and true technology

Our vaccine is built on protein subunit vaccine technology, a well-known and established platform for creating effective vaccines, used for diseases such as seasonal flu, human papillomavirus infection, and hepatitis B.

Spike protein

Coronaviruses use a protein on their surfaces, known as the spike protein, to attach themselves to human cells and cause infection. Our vaccine contains proteins that mimic the virus’ spike protein.

Nanoparticle

For our vaccine, we organize spike proteins into a nanoparticle to help the immune system learn and recognize the target spike protein on the surface of the COVID-19 virus.

Spike protein

Spike protein

Coronaviruses use a protein on their surfaces, known as the spike protein, to attach themselves to human cells and cause infection. Our vaccine contains proteins that mimic the virus’ spike protein.

Nanoparticle

Nanoparticle

For our vaccine, we organize spike proteins into a nanoparticle to help the immune system learn and recognize the target spike protein on the surface of the COVID-19 virus.


Our unique Matrix-M adjuvant is a key element of our protective technology

The Matrix-M adjuvant may bolster your body’s immune response when you receive a Novavax vaccine. When mixed with our vaccine protein nanoparticles, this combination of ingredients has been shown to enhance the immune system response to our vaccines.

Our Matrix-M adjuvant is derived from saponins, naturally occurring compounds in the bark of the Quillaja saponaria (soapbark) tree.

Once all the processing steps are complete, the Matrix-M adjuvant is mixed with vaccine nanoparticles to produce the finished, ready-to-use vaccine.

branch

Where does Matrix-M come from?

banner 3

Over 10 years of
vaccine development and innovation

We started with research into viruses like:

SARS

MERS

RSV

We are working to develop vaccines that will be practical as well as safe and effective

Convenient Storage

We’re developing vaccines with a focus on ease of storage and transportation

Improved Durability of Immune Response

Our nanoparticle technology, in combination with the Matrix-M adjuvant, helps promote a robust and more durable immune response

Efficient adaptability

Our proprietary approach allows us to engineer the vaccine antigen to update the vaccine as new variants emerge


Container

Sign up for news
about Novavax

We are continuing to study and respond to the COVID-19 endemic with multiple ongoing clinical studies and research into new vaccines.

Fill in the fields below, and we’ll keep you up to date with our latest news. All fields are required unless otherwise noted.

I agree to the statement below and have read and understand the Legal Disclaimer and Privacy Policy.

I authorize Novavax, and companies working with Novavax, to contact me by mail, email, fax, telephone, and/or text message (including autodialed and prerecorded calls and messages) for marketing purposes or otherwise provide me with information about Novavax’s products, services, and programs or other topics of interest, conduct market research or otherwise ask me about my experience with or thoughts about such topics. I understand and agree that any information that I provide may be used by Novavax to help develop new products, services, and programs. I understand that my consent is not required as a condition of purchasing or receiving any goods or services from Novavax. Note that Novavax will not sell or transfer your personal data to any unrelated third party for marketing purposes without your express permission. I understand that I may revoke this authorization and choose not to receive information from Novavax by clicking the “unsubscribe” link provided in the emails I receive from Novavax.

*US domestic mobile phone numbers only. By entering your mobile number you agree to receive SMS messages from 
Novavax and data rates may apply. You may receive multiple messages per day depending upon service conditions. 
Text HELP to 26968 for help. Text STOP to 26968 to cancel. See Terms and Conditions here and Privacy Policy here.